IL13RA2 and osteosarcoma: IL-13Rα2-overexpressing osteosarcoma cells were resistant to doxorubicin, as evidenced by higher cell proliferation and the colony-forming ability of cells and in vivo tumor growth in mice under treatment with the drug.